Jump to content

Dermatologists welcome antibiotics, α-adrenergic agonists and more


Guide

Recommended Posts

  • Root Admin

On the horizon, another α-adrenergic agonist, oxymetazoline 1% cream, likely will earn FDA approval in early 2017, predicted Drs. Harper and Webster. Allergan submitted the drug for FDA approval in mid-2016 and expects its Prescription Drug User Fee Act date in the first half of 2017, according to the company.

12th Annual Women's & Pediatric Dermatology Symposium 2016, Dermatology Times
Rosacea treatments
Dermatologists welcome antibiotics, α-adrenergic agonists and more

 

Link to comment
Share on other sites

Create an account or sign in to comment

You need to be a member in order to leave a comment

Create an account

Sign up for a new account in our community. It's easy!

Register a new account

Sign in

Already have an account? Sign in here.

Sign In Now
×
×
  • Create New...

Important Information

Terms of Use